Skip to main content
Journal cover image

ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update.

Publication ,  Journal Article
Expert Panel on Urological Imaging, ; Schieda, N; Oto, A; Allen, BC; Akin, O; Barker, SJ; Fulgham, PF; Gettle, LM; Maranchie, JK; Patel, BN ...
Published in: J Am Coll Radiol
May 2022

The staging and surveillance of testicular cancer is a complex topic, which integrates clinical, biochemical, and imaging components. The use of imaging for staging and surveillance of testicular cancer is individually tailored to each patient by considering tumor histology and prognosis. This document discusses the rationale for use of imaging by imaging modality during the initial staging of testicular seminoma and nonseminoma tumors and during the planned surveillance of stage IA and IB testicular cancer by histological subtype integrating clinical suspicion for disease recurrence in surveillance protocols. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

May 2022

Volume

19

Issue

5S

Start / End Page

S194 / S207

Location

United States

Related Subject Headings

  • United States
  • Testicular Neoplasms
  • Societies, Medical
  • Nuclear Medicine & Medical Imaging
  • Neoplasms, Germ Cell and Embryonal
  • Male
  • Humans
  • Evidence-Based Medicine
  • Diagnostic Imaging
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Expert Panel on Urological Imaging, ., Schieda, N., Oto, A., Allen, B. C., Akin, O., Barker, S. J., … Lockhart, M. E. (2022). ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. J Am Coll Radiol, 19(5S), S194–S207. https://doi.org/10.1016/j.jacr.2022.02.009
Expert Panel on Urological Imaging, Mark E., Nicola Schieda, Aytekin Oto, Brian C. Allen, Oguz Akin, Samantha J. Barker, Pat F. Fulgham, et al. “ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update.J Am Coll Radiol 19, no. 5S (May 2022): S194–207. https://doi.org/10.1016/j.jacr.2022.02.009.
Expert Panel on Urological Imaging, Schieda N, Oto A, Allen BC, Akin O, Barker SJ, et al. ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. J Am Coll Radiol. 2022 May;19(5S):S194–207.
Expert Panel on Urological Imaging, Mark E., et al. “ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update.J Am Coll Radiol, vol. 19, no. 5S, May 2022, pp. S194–207. Pubmed, doi:10.1016/j.jacr.2022.02.009.
Expert Panel on Urological Imaging, Schieda N, Oto A, Allen BC, Akin O, Barker SJ, Fulgham PF, Gettle LM, Maranchie JK, Patel BN, Schuster DM, Smith D, Turkbey IB, Lockhart ME. ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. J Am Coll Radiol. 2022 May;19(5S):S194–S207.
Journal cover image

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

May 2022

Volume

19

Issue

5S

Start / End Page

S194 / S207

Location

United States

Related Subject Headings

  • United States
  • Testicular Neoplasms
  • Societies, Medical
  • Nuclear Medicine & Medical Imaging
  • Neoplasms, Germ Cell and Embryonal
  • Male
  • Humans
  • Evidence-Based Medicine
  • Diagnostic Imaging
  • 3202 Clinical sciences